P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis

[1]  D. Planchard,et al.  Lung cancer in never-smokers , 2015, European Respiratory Journal.

[2]  Hua-Fu Zhou,et al.  Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer , 2012, Molecular Biology Reports.

[3]  X. Xiao,et al.  MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis , 2012, Tumor Biology.

[4]  S. Lei,et al.  An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk , 2012, Molecular Biology Reports.

[5]  H. Yu,et al.  TP53 Codon 72 Polymorphism with Hepatocellular Carcinoma: A Meta-Analysis , 2012, The Journal of international medical research.

[6]  A. Aboussekhra,et al.  The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. , 2012, Oncology letters.

[7]  Wei-Min Zhang,et al.  Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer. , 2011, Archives of medical research.

[8]  F. Fang,et al.  Meta-analysis of the relationship between p21 Ser31Arg polymorphism and lung cancer susceptibility. , 2011, Genetics and molecular research : GMR.

[9]  C. Dresler,et al.  Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. , 2011, Surgical oncology clinics of North America.

[10]  Q. Wei,et al.  Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck , 2011, Molecular carcinogenesis.

[11]  Min-Ho Shin,et al.  p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. , 2011, Lung cancer.

[12]  B. Ring,et al.  Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis , 2011, PloS one.

[13]  K. Sabapathy,et al.  Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore , 2010, BMC Cancer.

[14]  Yong Song,et al.  A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. , 2009, Lung cancer.

[15]  C. Mao,et al.  P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies , 2009, Human Genetics.

[16]  H. Shin,et al.  Association study of TP53 polymorphisms with lung cancer in a Korean population , 2008, Journal of Human Genetics.

[17]  Y. Nakanishi,et al.  EPHX1 Polymorphisms and the Risk of Lung Cancer: A HuGE Review , 2006, Epidemiology.

[18]  Wen Tan,et al.  Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer , 2006, Human mutation.

[19]  J. Yokota,et al.  Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk , 2005, International journal of cancer.

[20]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[21]  D. Wen,et al.  [p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population]. , 2003, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[22]  Ammarin Thakkinstian,et al.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. , 2003, Journal of clinical epidemiology.

[23]  Hidemi Ito,et al.  Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. , 2003, Asian Pacific journal of cancer prevention : APJCP.

[24]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  L. Le Marchand,et al.  Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  S. Rodin,et al.  Human lung cancer and p53: the interplay between mutagenesis and selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Miranda Thomas,et al.  Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.

[28]  J P Vandenbroucke,et al.  Bias in meta-analysis detected by a simple, graphical test , 1998 .

[29]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[30]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[31]  M. Tagawa,et al.  Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. , 1996, Carcinogenesis.

[32]  R. Birgander,et al.  p53 polymorphisms and haplotypes in different ethnic groups. , 1995, Human heredity.

[33]  G. Matlashewski,et al.  Molecular analysis of different allelic variants of wild-type human p53. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[34]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[35]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[36]  W. G. Cochran The comparison of percentages in matched samples. , 1950, Biometrika.

[37]  Qiushi Wang,et al.  Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population , 2012, Molecular Biology Reports.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  Yiming Wu Effects of p53 Arg/Pro gene polymorphism and smoking on the occurrence of lung cancer in Henan Han population , 2010 .

[40]  G. Shao,et al.  Association of polymorphism in TP53 gene with susceptibility and radiation sensitivity of non-small-cell-lung cancer in Chinese population , 2005 .

[41]  P. Hainaut,et al.  TP53 and mutations in human cancer. , 2003, Acta biochimica Polonica.

[42]  P. Lin,et al.  p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  L. Rubenstein,et al.  Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. , 1998, BMJ.